Journal: Matrix biology : journal of the International Society for Matrix Biology
Article Title: Skeletal pathology in mouse models of Gould syndrome is partially alleviated by genetically reducing TGFβ signaling
doi: 10.1016/j.matbio.2024.07.005
Figure Lengend Snippet: Genetically reducing Tgfb1 levels partially improves structural bone parameters in Col4a1 + /Δex41 mice. Morphometric analyses of femurs from 3 to 4 mo male mice. (A-B) Representative 3D images generated from μCT analysis of cortical and trabecular femoral bones from 3 to 4mo untreated (NT), 4PBA-treated, and Tgfb1 heterozygous Col4a1 +/+ (A) and Col4a1 + /Δex41 (B) mice. Scale bar=200μm. (C-E) Cortical bone parameters of the middle diaphysis and (F-J) trabecular bone parameters analyzed by μCT showing significant reductions in cortical thickness, trabecular bone density and number and significant increase in trabecular separation in untreated Col4a1 + /Δex41 mice compared their Col4a1 +/+ counterparts (D, F, G, and H, respectively). 4PBA treatment increased trabecular bone volume fraction and cortical and trabecular thicknesses in Col4a1 +/+ mice (F, D, and I). Although 4PBA improved trabecular number and separation (G, H) in Col4a1 + /Δex41 mice, it significantly decreased trabecular bone thickness and BMD (I and J). While Tgfb1 heterozygosity significantly reduced cortical and trabecular thickness and tended to reduce cortical BMD and trabecular bone volume fraction in Col4a1 +/+ mice (D, I, E, and F), it significantly improved trabecular bone number and separation and tended to increase trabecular bone volume fraction in Col4a1 + /Δex41 mice (G, H, and F, respectively). n = 9, 10, 8 for untreated, 4PBA-treated and Tgfb1 +/− Col4a1 +/+ mice and n = 12, 8, and 7 for untreated, 4PBA-treated and Tgfb1 +/− Col4a1 + /Δex41 mice, respectively. Data are presented as mean ± SD. ** P < 0.01; **** P < 0.0001, unpaired two-tailed Student t -test for comparison between untreated Col4a1 +/+ and Col4a1 + /Δex41 mice. ‡ p < 0.05; ‡‡ p < 0.001, one-way ANOVA (or Kruskal-Wallis and Dunnett pairwise tests for non-Gaussian distribution in F and H) to test the effect of 4PBA treatment and Tgfb1 heterozygosity in mice of a given genotype. Additional parameters are shown in .
Article Snippet: The conditional Col4a1 Flex41 mutant mouse was generated by InGenious Targeting Laboratory (Stony Brook, NY) and previously characterized and validated [ , ].
Techniques: Generated, Two Tailed Test, Comparison